Disse bivirkninger er ikke set i de kliniske forsøg, men de anses for at være relevante for den kliniske anvendelse: pancreas- øcelle- vacuolation, tubulær testikeldegeneration, gastrointestinale sårdannelser, knoglefrakturer og – callus, hepatisk hæmatopoiesis og pulmonær phospholipidose.
Adverse reactions not observed in clinical studies, but seen in animals at exposure levels similar to clinical exposure levels and with possible relevance to clinical use were as follows: pancreatic islet cell vacuolation, testicular tubular degeneration, gastrointestinal ulceration, bone fractures and calluses, hepatic haematopoiesis, and pulmonary phospholipidosis.